Edition:
United States

People: Bristol-Myers Squibb Co (BMY.N)

BMY.N on New York Stock Exchange

56.42USD
18 Aug 2017
Change (% chg)

$-0.35 (-0.62%)
Prev Close
$56.77
Open
$56.68
Day's High
$56.94
Day's Low
$56.41
Volume
1,885,658
Avg. Vol
2,007,109
52-wk High
$60.44
52-wk Low
$46.01

Lynch, Thomas 

Dr. Thomas J. Lynch, Jr., M.D., Ph.D., is appointed as Executive Vice President, Chief Scientific Officer of the Company., effective March 16, 2017. He has served as the Chairman and Chief Executive Officer of Massachusetts General Physicians Organization since July 2015. He has also served as a member of the Board of Directors of Massachusetts General Hospital since 2015. From 2009 to 2015, he was the Director of Yale Cancer Center and the Richard and Jonathan Sackler Professor of Internal Medicine, Yale Cancer Center, Yale School of Medicine. He also served as the Physician-in-Chief of Smilow Cancer Hospital, Yale-New Haven. Prior to 2009, he served as Professor of Medicine at Harvard Medical School and Chief of Hematology/Oncology at Massachusetts General Hospital. Dr. Lynch is a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the International Association for the Study of Lung Cancer.

Basic Compensation

Total Annual Compensation, USD 122,500
Restricted Stock Awards, USD 170,000
Long-Term Incentive Plans, USD --
All Other, USD 30,000
Fiscal Year Total, USD 322,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Giovanni Caforio

16,933,900

Charles Bancroft

6,971,690

Louis Schmukler

--

Ann Judge

--

Thomas Lynch

322,500

Sandra Leung

5,441,800
As Of  30 Dec 2016